Impaired vitamin K recycling in uremia is rescued by vitamin K supplementation

Kidney International

Volumn 86, Issue 2, 2014, Pages 286-293

  Kaesler, Nadine ^a   Magdeleyns, Elke ^b   Herfs, Marjolein ^b   Schettgen, Thomas ^a   Brandenburg, Vincent ^a   Fliser, Danilo ^c   Vermeer, Cees ^b   Floege, Jürgen ^a   Schlieper, Georg ^a   Krüger, Thilo ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

gamma carboxylase; nephropathy; vascular calcification; vitamin K

Indexed keywords

CALCIUM; CREATININE; DIHYDROLIPOAMIDE DEHYDROGENASE; FARNOQUINONE; OSTEOCALCIN; PHOSPHATE; PHYTOMENADIONE; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K EPOXIDE REDUCTASE; VITAMIN K GROUP; CALCIUM BINDING PROTEIN; GLUTAMYL CARBOXYLASE; LIGASE; MATRIX GLA PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CALCIFICATION; ARTICLE; BIOACCUMULATION; CALCIFICATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRAOSSEOUS CALCIFICATION; GAMMA GLUTAMYL CARBOXYLASE GENE; GENE EXPRESSION; HEART CALCIFICATION; KIDNEY CALCIFICATION; MALE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; UREMIA; VITAMIN K DEFICIENCY; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; ANIMAL; AORTA; BLOOD; CALCINOSIS; COMPLICATION; GENETICS; KIDNEY; LIVER; METABOLISM; WISTAR RAT;

ANIMALS; AORTA; CALCINOSIS; CALCIUM-BINDING PROTEINS; CARBON-CARBON LIGASES; EXTRACELLULAR MATRIX PROTEINS; KIDNEY; LIVER; MALE; NAD(P)H DEHYDROGENASE (QUINONE); RATS; RATS, WISTAR; UREMIA; VITAMIN K; VITAMIN K 1; VITAMIN K 2; VITAMIN K DEFICIENCY;

EID: 84905496780     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.530     Document Type: Article

References (38)

1. Raggi P, Boulay A, Scott CT et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701.
2. London GM, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740.
3. Ketteler M, Schlieper G, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension 2006; 47: 1027-1034.
4. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
5. Zebboudj AF, Imura M, Bostrom K. Matrix GLA Protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002; 277: 4388-4394.
6. Schurgers LJ, Spronk HM, Skepper JN et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007; 5: 2503-2511.
7. Hackeng TM, Rosing J, Spronk HM et al. Total chemical synthesis of human matrix Gla protein. Protein Sci 2001; 10: 864-870.
8. Stafford DW. The vitamin K cycle. J Thromb Haemost 2005; 3: 1873-1878.
9. Oldenburg J, Marinova M, Müller-Reible C et al. The vitamin K cycle. Vitam Horm 2008; 78: 35-62.
10. Koos R, Krueger T, Westenfeld R et al. Relation of circulating Matrix Gla- Protein and anticoagulation status in patients with aortic valve calcification. Thromb Haemost 2009; 101: 706-713.
11. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407.
12. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000; 20: 317-327.
13. Fusaro M, Tripepi G, Noale M et al. Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol 2013; epub ahead of print.
14. Villines T, O'Malley P, Feuerstein I et al. Does prolonged warfarin exposure potentiate coronary calcification in humans? Results of the warfarin and coronary calcification study. Calcif Tissue Int 2013; 85: 495-500.
15. Palaniswamy C, Aronow W, Sekhri A et al. Warfarin use and prevalence of coronary artery calcification assessed by multislice computed tomography. Am J Ther 2012; epub ahead of print.
16. Schurgers LJ, Spronk HM, Soute BA et al. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109: 2823-2831.
17. Westenfeld R, Krüger T, Schlieper G et al. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial. Am J Kidney Dis 2012; 59: 186-195.
18. Shea MK, O'Donnell CJ, Vermeer C et al. Circulating uncarboxylated matrix gla protein is associated with vitamin K nutritional status, but not coronary artery calcium, in older adults. J Nutr 2011; 141: 1529-1534.
19. Schlieper G, Westenfeld R, Krüger T et al. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD. J Am Soc Nephrol 2011; 22: 387-395.
20. Cranenburg E, Schurgers LJ, Uiterwijk HH et al. Vitamin K intake and status are low in hemodialysis patients. Kidney Int 2012; 82: 605-610.
21. Price PA, Roublick AM, Williamson MK. Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int 2006; 70: 1577-1583.
22. Geleijnse JM, Vermeer C, Grobbee DE et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004; 134: 3100-3105.
23. Al Rajabi A, Booth SL, Peterson JW et al. Deuterium-labeled phylloquinone has tissue-specific conversion to menaquinone-4 among Fischer 344 male rats. J Nutr 2012; 142: 841-845.
24. McCabe KM, Booth SL, Fu X et al. Dietary vitamin K and therapeutic warfarin alter the susceptibility to vascular calcification in experimental chronic kidney disease. Kidney Int 2013; 83: 835-844.
25. Shea MK, Booth SL, Miller ME et al. Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2013; 98: 197-208.
26. Truong J, Booth SL. Emerging issues in vitamin K research. JEBCAM 2011; 26: 73-79.
27. Montezano AC, Zimmerman D, Yusuf H et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 56: 453-362.
28. Krüger T, Oelenberg S, Kaesler N et al. Warfarin induces cardiovascular damage in mice. Arterioscler Thromb Vasc Biol 2013; 33: 2618-2624.
29. Shroff RC, McNair R, Skepper JN et al. Chronic mineral dysregulation promotes vascular smooth muscle cell adaption and extracellular matrix calcification. J Am Soc Nephrol 2010; 21: 103-112.
30. Suhara Y, Watanabe M, Motoyoshi S et al. Synthesis of new vitamin K analogues as steroid and xenobiotic receptor (SXR) agonists: insights into the biological role of the side chain part of vitamin K. J Med Chem 2011; 54: 4918-4922.
31. Kraus LM, Kraus AP. Carbamoylation of amino acids and proteins in uremia. Kidney Int 2001; 59: 102-107.
32. Cranenburg E, Brandenburg VM, Vermeer C et al. Uncarboxylated matrix Gla protein (ucMGP) is associated with coronary artery calcification in haemodialysis patients. Thromb Haemost 2009; 101: 359-366.
33. Schurgers LJ, Teunissen KJ, Knapen MH et al. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25: 1629-1633.
34. Kaesler N, Schettgen T, Mutucumarana VP et al. A fluorescent method to determine vitamin K-dependent gamma-glutamyl carboxylase activity. Anal Biochem 2012; 421: 411-416.
35. Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985; 150: 76-85.
36. Chu P, Huang TY, Williams J et al. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2. Proc Natl Acad Sci USA 2006; 103: 19308-19313.
37. Prochaska HJ, Santamaria AB. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem 1988; 169: 328-336.
38. Westenfeld R, Schaefer C, Smeets R et al. Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice. Nephrol Dial Transplant 2007; 22: 1537-1546.